7 апр. 2024 г. · Added value of this study. ULTIMATE-DAPT is the first randomised controlled trial to compare dual antiplatelet therapy with a potent platelet ... |
7 апр. 2024 г. · The placebo-controlled trial, conducted at 58 medical centers in China, Pakistan, Italy and the U.K., randomized 3,400 patients who had ... |
8 мая 2024 г. · – Randomized multicenter trial – Patients were randomized to receive ticagrelor monotherapy (90 mg twice daily) after 3-month DAPT (n = 1527) or ... |
27 окт. 2024 г. · The ULTIMATE-DAPT trial showed that compared with standard 12-month DAPT with aspirin and ticagrelor, 1-month DAPT followed by de-escalation ... |
7 апр. 2024 г. · Methods: In this randomised, placebo-controlled, double-blind clinical trial, patients aged 18 years or older with an acute coronary syndrome ... Не найдено: nejm | Нужно включить: nejm |
13 мая 2024 г. · A clinical trial in China suggests better outcomes with long-term clopidogrel monotherapy than DAPT. For patients with acute coronary ... |
8 янв. 2024 г. · These authors conducted a randomized trial from more than 200 centers in China to assess DAPT with aspirin and clopidogrel. The trial was ... |
The multicenter randomized ULTIMATE (Intravascular Ultrasound Guided Drug Eluting Stents Implantation in “All-Comers” Coronary Lesions) trial showed a lower ... |
7 апр. 2024 г. · Stone, MD (Icahn School of Medicine at Mount Sinai, New York, NY), who presented the ULTIMATE-DAPT trial today at the American College of ... Не найдено: nejm | Нужно включить: nejm |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |